Displaying 1 - 20 of 71 results
Released Company Title Industry Topic
03 Sep 2020
15:09 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Announces Notice of its Ordinary General Meeting of Shareholders to be Held on September 30, 2020 20103010 Biotechnology General meeting / Board Meeting
27 Aug 2020
19:10 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG plans conversion into Naamloze Vennootschap (N.V.) under Dutch law 20103010 Biotechnology Other subject
27 Aug 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports Financial Results for H1 2020 and Provides Corporate Update 20103010 Biotechnology Commercial results
20 Aug 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 20103010 Biotechnology Other subject
20 Aug 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its Half Year 2020 Results on August 27, 2020 20103010 Biotechnology Other subject
04 Aug 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Receives IND Approval for Varoglutamstat's (PQ912) Phase 2 Study in Alzheimer's Disease 20103010 Biotechnology Other subject
15 Jul 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Announces Enrollment of First Patient in VIVIAD, European Phase 2b Alzheimer's Disease Study with Varoglutamstat (PQ912) 20103010 Biotechnology Trends / Analyses
26 Jun 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Provides Update on US and EU Alzheimer's Clinical Trial Program with PQ912 20103010 Biotechnology Other subject
14 May 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports First Quarter 2020 Biotechnology Commercial results
12 May 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Postpones Annual General Meeting Biotechnology General meeting / Board Meeting
07 May 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its First Quarter 2020 Business Update on May 14, 2020 Biotechnology Other subject
29 Apr 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Announces Outcome of Exclusive Option Deal with MorphoSys Biotechnology Other subject
16 Apr 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Starts Development Program for Meprin Protease Inhibitors with Intended Therapeutic Use in Fibrosis, Cancer and Alzheimer's Disease Biotechnology Legal
26 Mar 2020
13:10 CET
VIVORYON Correction of a release from 26/03/2020, 07:00 CET/CEST - Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports Full Year 2019 Financial Results Biotechnology Commercial results
26 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports Full Year 2019 Financial Results Biotechnology Commercial results
19 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] Biotechnology Other subject
19 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its Full Year 2019 Results on March 26, 2020 Biotechnology Other subject
18 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Announces Update on Phase 2b Alzheimer's Clinical Trial, VIVIAD Biotechnology Trends / Analyses
03 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics to Attend Upcoming Investor Conferences Biotechnology Meetings / events
14 Jan 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration Biotechnology News contracts